Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 8/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | MMP2 | P08253 | 9/20 | 0.60 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | CTSL | P07711 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | MMP1 | P03956 | 1/20 | 0.54 |
| ▸ | MMP3 | P08254 | 1/20 | 0.54 |
| ▸ | MMP7 | P09237 | 1/20 | 0.54 |
| ▸ | MMP13 | P45452 | 1/20 | 0.54 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tpck SCHEMBL441444 | 1.00 | MMP9 (0.61) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL669507 | 0.89 | MMP9 (0.60) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL2213327 | 0.89 | MMP9 (0.60) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL15213278 | 0.88 | MMP9 (0.63) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL433895 | 0.88 | MMP9 (0.69) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL1523717 | 0.88 | MMP9 (0.69) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL31230483 | 0.87 | MMP9 (0.61) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL628640 | 0.87 | MMP9 (0.64) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| SCHEMBL20601786 | 0.87 | MMP9 (0.64) | MMP9TDP1MMP2ADAMTS4ALDH1A1 | |
| Chloromethane SCHEMBL7649372 | 0.87 | MMP2 (0.75) | MMP9TDP1MMP2ADAMTS4ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2097 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12458582-B2 | Stabilized hyaluronic acid | CROMA-PHARMA GMBH (AT) | 2025-11-04 | — | — | US | claimed |
| US-20250281579-A1 | Methods and Compositions for Oral Administration of Proteins | ORAMED PHARMACEUTICALS INC (IL) | 2025-09-11 | — | — | US | claimed |
| CN-119842856-A | Method for screening antiviral drugs | 中国疾病预防控制中心病毒病预防控制所 | 2025-04-18 | — | — | CN | claimed |
| CN-119791066-A | Method for rescuing H1N1 recombinant influenza A virus carrying green fluorescent protein and preparing mouse adaptation strain | 浙江理工大学 | 2025-04-11 | — | — | CN | claimed |
| CN-119752816-A | Efficient screening method for influenza virus candidate vaccine strain and application thereof | 深圳康泰生物制品股份有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-119709636-A | Zinc ion-containing influenza A virus culture medium and preparation method thereof | 浙江大学 | 2025-03-28 | — | — | CN | claimed |
| CN-119662438-A | Genetically engineered bacterium, method for constructing same and method for preparing emodin and physcion by using genetically engineered bacterium | 上海微创生成生物技术有限公司 | 2025-03-21 | — | — | CN | claimed |
| CN-119506228-A | Method for culturing avian influenza virus | 天康制药股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-116479047-B | Newcastle disease virus double-plasmid rescue system, construction method, identification method and application thereof | 吉林农业大学 | 2024-11-01 | — | — | CN | claimed |
| CN-117825542-B | Marker composition for hemoglobinopathy, screening reagent and application thereof | 重庆医科大学附属儿童医院 | 2024-10-29 | — | — | CN | claimed |
| CN-114836390-A | H9N2 subtype avian influenza virus MDCK cell cold-adaptation attenuated live vaccine strain and cultivation method and application thereof | 华南农业大学 | 2022-08-02 | — | — | CN | claimed |
| CN-112961837-B | Newcastle disease VII type low virulent strain serum-free whole suspension cell culture method | 武汉科前生物股份有限公司 | 2022-07-12 | — | — | CN | claimed |
| US-20220160839-A1 | METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS | ORAMED PHARMACEUTICALS, INC. (IL) | 2022-05-26 | — | — | US | claimed |
| CN-114438019-A | Domestication method of MDCK cell line | 上海荣盛生物药业股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-108300704-B | Method for suspension culture of infectious bronchitis virus by using continuous cell line | 华农（肇庆）生物产业技术研究院有限公司 | 2022-04-05 | — | — | CN | claimed |
| CN-114262694-A | Novel coronavirus vaccine candidate strain taking B-type influenza virus as carrier and construction method and application thereof | 军事科学院军事医学研究院军事兽医研究所 | 2022-04-01 | — | — | CN | claimed |
| CN-114206214-A | Compositions, methods and systems for protein corona analysis of biological fluids and uses thereof | 禧尔公司 | 2022-03-18 | — | — | CN | claimed |
| CN-114107223-A | Method for improving culture titer of SARS-CoV-2 virus cells by TPCK pancreatin | 湖北省疾病预防控制中心（湖北省预防医学科学院） | 2022-03-01 | — | — | CN | claimed |
| US-20220048979-A1 | TREATMENT OF STAPHYLOCOCCAL DISORDERS | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERAN AFFAIRS | 2022-02-17 | — | — | US | claimed |
| EP-3946054-A1 | COMPOSITIONS, METHODS AND SYSTEMS FOR PROTEIN CORONA ANALYSIS FROM BIOFLUIDS AND USES THEREOF | Seer, Inc. (US) | 2022-02-09 | — | — | EP | claimed |